Neuropsychiatric symptoms and functional decline in alzheimerʼs disease and lewy body dementia

Background/objectives: Functional status is one of the most important markers of well-being in older adults, but the drivers of functional decline in dementia are not well known. The aim of our work was to study the association of neuropsychiatric symptoms (NPSs) with functional decline over 5 years...

Full description

Autores:
Borda, Miguel Germán
Aarsland, Dag
Tovar Rios, Diego Alejandro
Ballard, Clive
González, María Camila
Alves, Guido
Oppedal, Ketil
Vik-Mo, Audun Osland
Giil, Lasse Melvaer
Bronnick, Kolbjorn
Soennesyn, Hogne
Tipo de recurso:
Article of journal
Fecha de publicación:
2020
Institución:
Universidad Autónoma de Occidente
Repositorio:
RED: Repositorio Educativo Digital UAO
Idioma:
eng
OAI Identifier:
oai:red.uao.edu.co:10614/13248
Acceso en línea:
https://hdl.handle.net/10614/13248
https://doi.org/10.1111/jgs.16709
Palabra clave:
Enfermedad de Alzheimer
Demencia
Neuropsiquiatría
Dementia
Functional status
Alzheimerʼs disease
Lewy body dementia
Neuropsychiatric symptoms
Rights
openAccess
License
Derechos reservados - Journal of the American Geriatrics Society, 2020
Description
Summary:Background/objectives: Functional status is one of the most important markers of well-being in older adults, but the drivers of functional decline in dementia are not well known. The aim of our work was to study the association of neuropsychiatric symptoms (NPSs) with functional decline over 5 years in newly diagnosed people with Alzheimer´s disease (AD) and Lewy body dementia (LBD). Design: Secondary analysis of the Dementia Study of Western Norway longitudinal cohort study. Setting: Multicenter study conducted in memory clinics in western Norway. Participants: We included a total of 196 patients newly diagnosed with AD (n = 111) and LBD (n = 85), followed up annually for 5 years. Main Outcomes and Measures: The outcome was the rapid disability rating scale (items 1-13). Linear mixed-effects models were used for analysis with the total score of the Norwegian Neuropsychiatric Inventory (NPI) as a predictor measured either at baseline or longitudinally, adjusted for potential confounders, including cognition. Effect modification was checked by introducing interactions with NPI score and stratifying by diagnosis. Results: The total NPI score longitudinal course was associated with functional decline in both AD and LBD. At baseline, the total NPI score predicted functional decline in AD. Conclusion: NPSs were associated with the rate of functional decline in people with AD and LBD, independent of cognitive impairment. These results highlight the relevance of early detection and intervention of NPSs, which may also reduce functional decline.